Morgans Financial, sponsor of the 2022 National Bionics Innovation Prize, is a market leader with a 35-year history of providing financial advice to Australian investors.
The company’s insights on capital raising and corporate advisory solutions assist businesses across all sectors including those in health and medtech product development, manufacturing and service delivery.
Morgans’ award-winning research team provides analysis on 200+ ASX-listed companies and regular market updates plus a team of analysts with unique industry insights.
Sponsorship of Bionics Challenge 2022 by Morgans Financial saw the winner of the National Bionics Innovation Prize receive $30,000 plus the equivalent value in fundraising advice and mentoring.
Morgans’ team of experienced and dedicated professionals in Brisbane, Sydney, Melbourne and Perth give Australian companies direct access to equity capital markets through a far reaching network of retail and institutional investors.
Since the early 1990s, Morgans Corporate team has structured and raised more than $30 billion in new capital for clients in over 1,500 transactions and managed mergers and acquisitions (M&A) transactions worth a combined total of $11.5 billion.